74/100 B+ · Moderate risk
No major risk flags in the public sources we cover Indicative TraceComp estimate from public sources — an automated indicator, not a credit decision, a completed due-diligence check, or a guarantee. Verify against the official register.

ℹ️ No matches surfaced in the limited public sources we cover (sanctions, screening, insolvency, control). This is an automated indicator — not an exhaustive check, a credit decision, or a guarantee, and absence of a match does not mean none exists. Verify against the official register.

ALGOTHERAPEUTIX

Active Simplified joint-stock company (SAS) Scientific research & development Active for 8 years

Simplified joint-stock company (SAS) · RC 839726783 · Active since 2018

B+

Overview

ALGOTHERAPEUTIX is a simplified joint-stock company (sas) registered in France, since 2018. The company operates in the scientific research & development sector. Its TraceComp score of 74 (B+) indicates moderate risk with some areas to watch.

Company Information

Registration Number
839726783
Legal Form
Simplified joint-stock company (SAS)
Registered
2018-04-30

Officers & Management

2 officers/directors on file — names, roles, appointment & resignation dates.

NameRoleStatus
A••••• C•••••• Statutory auditor Current
E•• A•••••• Officer Current

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Patent Portfolio

Active patent holder. 3 patents · 3 active · 3 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • No financial filings on record — score derives from registry signals and sector context

Data Sources & Freshness

Data sourced from: bulk register.